Carcinoma: all 6,718 studies

Page 29 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCCActive, not recruitingNCT05433701Not applicable
• 68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma PatientsCompletedNCT05432947Not applicable
• Immunological Variables Associated to ICI Toxicity in Cancer PatientsStatus unknownNCT05429866Phase 2
• SOX2 & PDL1 Expression on Urinary Bladder CarcinomaStatus unknownNCT05429710
• Expression of STEAP-1 and p40 in Prostatic Carcinoma and Its MimickersStatus unknownNCT05428319
• ctDNA-based MRD Assessment in Local Advanced Esophageal CarcinomaStatus unknownNCT05426850
• Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of EsophagusStatus unknownNCT05424432Phase 2
• Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)CompletedNCT05422781Phase 1
• Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCCStatus unknownNCT05420922
• A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in ArizonaWithdrawnNCT05418387Not applicable
• Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center StudyStatus unknownNCT05418309Phase 2
• Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular CarcinomaStatus unknownNCT05416073Phase 4
• Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungWithdrawnNCT05412875Not applicable
• Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular CarcinomaStatus unknownNCT05411926
• Oral Iloprost for the Prevention of Lung Cancer In Former SmokersWithdrawnNCT05411107Phase 2
• Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid CancerCompletedNCT05410821Phase 1
• Effects of Antiviral Therapy on Patients With HBV-related HCCCompletedNCT05406089
• Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsmsStatus unknownNCT05402046Not applicable
• Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma TreatmentStatus unknownNCT05397860Not applicable
• Efficacy and Safety of T+A+RAD in HCCStatus unknownNCT05396937Phase 2
• An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UKCompletedNCT05394493
• Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular CarcinomaStatus unknownNCT05391867Not applicable
• Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of ChemoembolizationStatus unknownNCT05390112
• PET/MRI in Endometrial CancerWithdrawnNCT05390021Not applicable
• Pembrolizumab and Lenvatinib for Resectable Hepatocellular CarcinomaActive, not recruitingNCT05389527Phase 2
• Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT05386056Phase 2
• Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical StudyStatus unknownNCT05381636Phase 2
• Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric OriginCompletedNCT05379790Phase 1
• Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing MesothelinWithdrawnNCT05375825Phase 1
• A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)TerminatedNCT05375604Phase 1
• A Study of Lenvatinib in Combination With Pembrolizumab in Korean PatientsCompletedNCT05375136
• Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)Status unknownNCT05372302
• ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian CancerWithdrawnNCT05368506Early Phase 1
• Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer SurvivorsCompletedNCT05364450Not applicable
• A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT05363722Phase 1
• A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursTerminatedNCT05363605Phase 1/2
• Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With HematuriaCompletedNCT05362539Not applicable
• INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT05359692Phase 2
• Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal CarcinomaCompletedNCT05355168Phase 2
• Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver TransplantationStatus unknownNCT05355155Phase 2
• A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128Active, not recruitingNCT05354102Phase 1
• GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular CarcinomaTerminatedNCT05352542Phase 1
• Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular CarcinomasCompletedNCT05352204
• Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCCStatus unknownNCT05351762Phase 2
• Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)Active, not recruitingNCT05349890Phase 1
• Detection of Disease in the Upper TractWithdrawnNCT05349812
• Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal MedullaActive, not recruitingNCT05347212Phase 2
• Himalaya Early Access ProgramApproved for marketingNCT05345678
• TACE Combined With Penpulimab and Anlotinib for Advanced HCCStatus unknownNCT05344924Phase 2/3
• The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical CarcinomaCompletedNCT05344027
• International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyTerminatedNCT05342350
• Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.CompletedNCT05340569Not applicable
• Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)Status unknownNCT05340543
• IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver TransplantationStatus unknownNCT05339581Not applicable
• Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid TumorsWithdrawnNCT05338580Phase 2
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaCompletedNCT05337163
• Hearing Impairment of Nasopharyngeal CarcinomaCompletedNCT05330169
• Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular CarcinomaWithdrawnNCT05327738Phase 2
• New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma ManagementStatus unknownNCT05324202Not applicable
• A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell CarcinomaTerminatedNCT05322135Early Phase 1
• A Phase II Study of AK104 Plus Lenvatinib and TACE in HCCActive, not recruitingNCT05319431Phase 2
• A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial CarcinomaStatus unknownNCT05318339Phase 2
• A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCCStatus unknownNCT05317325Phase 1
• Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line TherapyWithdrawnNCT05315687Phase 2
• Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular CarcinomaStatus unknownNCT05312216Phase 2
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsActive, not recruitingNCT05311618Phase 1
• Tislelizumab and Radiotherapy for Recurrent Cervical CancerStatus unknownNCT05310383Phase 2
• Chromosomal Instability in Ovarian CancerStatus unknownNCT05310357
• Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT05310344Phase 2
• Donafenib for Recurrent Cervical CancerStatus unknownNCT05310331Phase 2
• PD-1 Antibody and Radiotherapy for Recurrent Cervical CancerStatus unknownNCT05310305
• Postoperative Adjuvant Therapy of HCC Based on PD-1CompletedNCT05307926
• Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung CancerCompletedNCT05304793Not applicable
• Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction AngiographyCompletedNCT05304572
• Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal CarcinomainActive, not recruitingNCT05304468Phase 3
• Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT05302011Phase 2
• Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer PatientsCompletedNCT05300789
• BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)Status unknownNCT05299203Phase 1
• Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor TherapyWithdrawnNCT05295589Phase 2
• IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag GovernorateStatus unknownNCT05293327
• Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal CarcinomaCompletedNCT05292027Not applicable
• Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and NeckStatus unknownNCT05291663
• Pharmacogenetic Study in Hepatocellular Carcinoma Patients.CompletedNCT05291338
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center TrialStatus unknownNCT05290935Phase 2
• HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular CarcinomaStatus unknownNCT05290220Phase 2
• Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCCStatus unknownNCT05287880
• The Surveillance of Hepatocellular CarcinomaStatus unknownNCT05286099
• Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT05282433Phase 2
• A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma PatientsStatus unknownNCT05281926Phase 1
• RFA for Treatment of Intermediate Stage HCCCompletedNCT05281783Not applicable
• Lipiodol-TACE With Idarubicin for Hepatocellular CarcinomaStatus unknownNCT05280444Phase 2/3
• Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging BiomarkersStatus unknownNCT05278195
• Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)Status unknownNCT05277675Not applicable
• Plan for Microwave Thermal FieldStatus unknownNCT05270642Not applicable
• Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 BlockadeStatus unknownNCT05265962Phase 2
• Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or CarcinosarcomaStatus unknownNCT05265793Phase 2
• The Pharmacological Effects of Using Cabozantinib With a Light BreakfastCompletedNCT05263245Phase 2
• Retro-Auricular Single-Site Endoscopic to Papillary Thyroid CarcinomaCompletedNCT05263141Not applicable
• A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC)Status unknownNCT05262413Phase 1/2
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentActive, not recruitingNCT05261399Phase 3

← Carcinoma overview